2007'02.10.Sat
Atticus Capital LP Opposes Genzyme Bid for AnorMED

September 13, 2006

NEW YORK, Sept. 13 /Xinhua-PRNewswire/ -- Atticus Capital LP does not support Genzyme Corporation's (GENZ) bid for AnorMED Inc. (ANOR), believing that it is not in the best interest of shareholders. "We think the Genzyme bid undervalues the company, and support the efforts of AnorMED and its advisors to seek better alternatives," stated an Atticus spokesman. Atticus Capital currently owns 9.1% of the outstanding shares of AnorMED. For more information, please contact: Robert Coburn of Atticus Capital LP Tel: +1-212-373-0800 SOURCE Atticus Capital LP
PR
Post your Comment
広告
ブログ内検索
アーカイブ
カウンター